Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|September 24, 2015
Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical UtilityRicardo Martinez, Alessandra Blasina, Jill F Hallin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer modelsCathy C Zhang, Adam Pavlicek, Qin Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2011
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cellsCathy C Zhang, Zhengming Yan, Wenlin Li, et al.Plos One|July 5, 2013
Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA MutationDouglas D Fang, Cathy C Zhang, Yin Gu, et al.Arthritis and Rheumatism|November 13, 2003
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulatorKevin P Baker, Bryan M Edwards, Sarah H Main, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutationsHelen Y Zou, Qiuhua Li, Lars D Engstrom, et al.Cancer Cell|July 7, 2015
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical ModelsHelen Y Zou, Luc Friboulet, David P Kodack, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2012
Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenicJonah B Sacha, In-Jeong Kim, Lianchun Chen, et al.Pageof 2